Interventional Cardiology Devices: World Market Prospects 2011-202115 Nov 2011 • by Natalie Aster
The PTCA Balloon market in 2010 was valued at $1.9bn, which represents a 19.4% share of the total interventional cardiology devices market. PTCA balloon market is the second largest sector in the interventional cardiology devices market behind coronary stents.
The PTCA balloon market is dominated by four main companies occupying a total of 86% of the global market with sales of $1.6bn in 2010. The big four companies will increase their market share during the period 2011 to 2021, Visiongain predicts.
Interventional Cardiology Devices: World Market Prospects 2011-2021
Published: September 2011
Price: US$ 2,664.00
Report Sample Abstract
Market Shares(%) of Leading Companies in the PTCA Balloon Market, 2010
Source: Visiongain 2011
PTCA Balloon Market Forecast, 2011-2021
During the period 2010 to 2021, the PTCA balloon market is forecast to grow from $1.9bn in 2010 to $4.0bn in 2021. Growth in the period 2010 to 2015 will be at a CAGR of 9.4%, compared with a CAGR rate of 5.2% during the period 2015 to 2021.
Growth will be driven by emerging economies such as China and India. The number of PTCA balloon angioplasty procedures carried out in China has risen from 68,000 in 2002 to 653,000 in 2009, with an annual average growth rate of 38%. Visiongain predicts this rise to continue and drive the market. Growth will also be driven by new innovative products such as drug eluting balloons (DEBs). The PTCA balloon catheter does not only serve as a treatment method, but also as a delivery method for coronary stents. This dual purpose means that as the stent market increases the PTCA balloon catheter market will increase. This will also drive growth during the period 2010 to 2015.
More information can be found in the report “Interventional Cardiology Devices: World Market Prospects 2011-2021” by Visiongain.
To order the report or ask for sample pages contact firstname.lastname@example.org